Concurrent use of nivolumab and radiotherapy for patients with metastatic non‑small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab

Ansari, J., Farrag, A., Ali, A. et al. (7 more authors) (2021) Concurrent use of nivolumab and radiotherapy for patients with metastatic non‑small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab. Molecular and Clinical Oncology, 15 (4). 214. ISSN 2049-9450

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Ansari et al. This is an open access article distributed under the terms of Creative Commons Attribution License. https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: nivolumab; renal cell carcinoma; lung cancer; concurrent; radiotherapy; stereotactic body radiotherapy; checkpoint inhibitors; pseudoprogression
Dates:
  • Accepted: 9 July 2021
  • Published (online): 23 August 2021
  • Published: October 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 11 May 2022 15:50
Last Modified: 11 May 2022 16:01
Status: Published
Publisher: Spandidos Publications
Refereed: Yes
Identification Number: https://doi.org/10.3892/mco.2021.2376
Related URLs:

Share / Export

Statistics